comparemela.com

Latest Breaking News On - சோதனை சிகிச்சை - Page 11 : comparemela.com

Immuno-PET can give physicians early insight into tumor response to targeted therapy

 E-Mail IMAGE: Three receptor tyrosine kinases (RTKs) EGFR (orange), HER2 (pink), and MET (green) are imaged before and after the use of a MET-selective tyrosine kinase inhibitor (Trametinib), and trametinib, a mitogen activated protein. view more  Credit: Image created by Patricia Pereira, PhD, Research Associate at Memorial Sloan Kettering Cancer Center Reston, VA Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor s response to targeted therapy, allowing physicians to select the most effective treatment for patients who have cancer. The new research was published in the March issue of The Journal of Nuclear Medicine. The research showed that immuno-PET successfully visualizes changes in different cancer receptors (receptor tyrosine kinases, or RTKs) within tumors during targeted therapies. This gives physicians a tool that can be used to evaluate the effectiveness of a treatment soon after its administration.

Smoking cessation drug shows potential to treat Parkinson s disease in females

Smoking cessation drug shows potential to treat Parkinson s disease in females Texas A&M University College of Medicine ressearchers have recently discovered that cytisine a smoking cessation drug commonly used in Europe reduces the loss of dopamine neurons in females. These findings provide potential evidence for the use of the drug to treat Parkinson s disease or stop its progression in women. Sara Zarate and Gauri Pandey, graduate students from the lab of Rahul Srinivasan, assistant professor in the Department of Neuroscience & Experimental Therapeutics, are co-first authors of the research. Their findings are published in the Journal of Neurochemistry.

Texas A&M: Smoking Cessation Drug May Treat Parkinson s In Women – India Education,Education News India,Education News

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.